Anticorps Recombinant de lapin anti-ELOVL4

ELOVL4 Recombinant Antibody for FC (Intra), ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

FC (Intra), ELISA

Conjugaison

Non conjugué

CloneNo.

240608A11

N° de cat : 84050-1-PBS

Synonymes

ELOVL fatty acid elongase 4, ELOVL FA elongase 4, EC:2.3.1.199, ADMD, 3-keto acyl-CoA synthase ELOVL4



Informations sur le produit

84050-1-PBS cible ELOVL4 dans les applications de FC (Intra), ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène Peptide
Nom complet elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4
Masse moléculaire calculée 37 kDa
Numéro d’acquisition GenBankNM_022726
Symbole du gène ELOVL4
Identification du gène (NCBI) 6785
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Protein A purfication
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

ELOVL4, also named as ADMD, STGD2 and STGD3, belongs to the ELO family. It is a component of the fatty acid elongation system. Elovl4 is involved in the biosynthesis of very long chain fatty acids. It seems to represent a photoreceptor-specific component of the fatty acid elongation system residing on the endoplasmic reticulum. ELOVL4 may be implicated in docosahexaenoic acid (DHA) biosynthesis, which requires dietary consumption of the essential alpha-linolenic acid and a subsequent series of three elongation steps. Defects in ELOVL4 are the cause of Stargardt disease type 3 (STGD3). The antibody is specific to ELOVL4.

{{ptg:RelatedPrimaryAntibodies}}